6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
Just now	Euroseas Ltd. Announces Expansion of its Feeder Containership Newbuilding Program Ordering Two 2,800 teu High-Reefer Vessels and Two 1,800 teu Vessels
Just now	Boxlight Announces Significant Upgrades to Symphony™ Campuswide Communication Platform
Just now	Satellogic Signs $12 Million Agreement to Deliver In-Orbit NewSat Satellite to Sovereign Defense Customer
1m ago	The Fortinet 2026 Global Threat Landscape Report Reveals a Surge in AI-Enabled Cybercrime, Contributing to a 389% Increase in Ransomware Victims Year-over-Year
1m ago	Life & Banc Split Corp. Completes Preferred Share Offering

About

Eupraxia Pharmaceuticals Inc (TO:EPRX) — investor relations, events, news, and company updates on 6ix.

Latest News

Eupraxia Pharmaceuticals to Present at Digestive Disease Week Annual Meeting

Eupraxia Pharmaceuticals Reports Positive Nine-Month Tissue Health and Symptom Data from the Highest Dose Cohort in its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis 

Eupraxia Pharmaceuticals to Present at Upcoming Investor Conferences

Eupraxia Pharmaceuticals Reports Six-Month Symptom Data from the Highest Dose Cohort in its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis

Eupraxia Pharmaceuticals Reports Fourth Quarter 2025 Financial Results

Financials

Revenue

CA$0

Market Cap

CA$611.96 M

EPS

-1.43

Community Chat

Ask AI